Astellas

Business Briefs: Amgen and Astellas; GSK; Teva; Novo; Livestrong

Amgen and Astellas team up to take on Japan; GSK acquires Swiss vaccine developer's innovative platform; Ireland makes generic switches easier; Novo backs wet AMD therapy; Nike ditches Livestrong

Tarceva diagnostic brings new indication

Tarceva diagnostic brings new indication

By

Tarceva picks up a first-line indication and a companion diagnostic

Email Newsletters